Le Lézard
Classified in: Health, Business
Subjects: SBS, CXP

A Better Weigh, Inc. Launches Franchise Opportunity Worth the Weight, Sets Sights on National Expansion


CHICAGO, Jan. 6, 2022 /PRNewswire/ -- Today, A Better Weigh, Inc., a Chicago-based weight loss center announced its plans for a national franchise expansion. Since its founding in 2009, the center has provided faster, safer and longer-lasting weight loss results using FDA-approved medications, lipotropic formulas and proprietary supplements and attracted over 20,000 customers to its four locations. With the global weight loss industry projected to increase from $254.9 billion in 2021 to $377.3 billion by 2026 (Research and Markets, 2020), the woman-owned company hopes to capitalize on consumer demand by bringing its unique approach of customized medically-assisted weight loss and weight management programs to potential business owners across the country.

Founded by Chanay Walton, LPN after her own struggles with postpartum weight loss and through her work as a nurse, Chanay realized the importance of diet, nutrition and weight management, which led her to open the first A Better Weigh location in the Beverly neighborhood of Chicago in 2009. Since then, she has expanded to one additional corporate location in the Edgewater neighborhood of Chicago and two franchise locations in Tinley Park, Illinois and Schererville, Indiana. Now, the company hopes to expand its proven franchise model throughout the Midwest, and then nationally.

"Looking at the industry demand combined with our proven franchise model, our team looks forward to finding new business owners looking to capitalize on this trend with A Better Weigh," said Walton. "We are changing the way that people look at weight loss and weight management and making it something attainable and realistic, working with every patient to their unique goals and desired lifestyle." 

A Better Weigh's approach to weight loss and management is informed by a team of physicians, nutritionists and coaches to provide a true 360 degree comprehensive solution. Most programs include a guided meal plan, proprietary supplements, proprietary injections to stimulate metabolism and increase fat burning processes, and consistent appointments and consultations with the A Better Weigh care team. Unique to A Better Weigh, each location offers FDA-approved medications, supplements, Lipo-Ignite injections and focuses on healthy BMIs when working with patients.

A Better Weigh is actively seeking franchisees across the nation for those who have a medical background and a passion to help people feel their best, customer service skills, and who meet the financial requirements. Including a franchise fee of $50,000, the estimated initial investment to open A Better Weigh franchise starts at $108,000.

For more information about franchising with A Better Weigh visit: https://betterweighmedical.com/franchise

ABOUT A BETTER WEIGH 
A Better Weigh is a Chicago-based weight loss center bringing faster, safer and long-lasting weight loss results using FDA-approved medications, lipotropic formulas and proprietary supplements. For more information and to learn more about A Better Weigh franchise opportunity, please visit https://betterweighmedical.com/.

MEDIA CONTACT
RACHEL SHAYKIN
MEKKY MEDIA RELATIONS
(847) 331-5861
[email protected]

SOURCE A Better Weigh


These press releases may also interest you

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:19
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...



News published on and distributed by: